- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07704710
The Effect of Pulse Oximeter Probe Replacement Interval on Pressure Injury Development in Intensive Care Patients
"The Effect of Pulse Oximeter Probe Replacement Interval on Pressure Injury Development in Intensive Care Patients: A Randomized Controlled Trial"
Study Overview
Status
Conditions
Detailed Description
Pulse oximetry is a non-invasive monitoring method that continuously measures arterial oxygen saturation (SpO₂) and pulse rate using optical sensors placed on peripheral tissues. It is widely used in intensive care units (ICUs), operating rooms, and other critical care settings for continuous patient monitoring . Although essential for patient care, prolonged application of pulse oximeter probes to the same anatomical site may increase the risk of medical device-related pressure injuries (MDRPIs), particularly in critically ill patients with impaired tissue perfusion, immobility, and fragile skin.
Medical device-related pressure injuries represent a substantial proportion of hospital-acquired pressure injuries and are associated with increased morbidity, prolonged hospitalization, and healthcare costs. International clinical practice guidelines recommend frequent skin assessment, regular repositioning of medical devices, prompt removal of unnecessary devices, and interventions to reduce pressure. However, these guidelines do not define an evidence-based interval for repositioning pulse oximeter probes, and current clinical practice varies considerably among healthcare institutions.
Several case reports have described tissue injury associated with prolonged pulse oximeter sensor application, including skin erosion and tissue necrosis at the finger, toe, ear, and forehead. Nevertheless, high-quality randomized controlled trials evaluating the optimal pulse oximeter probe replacement interval are lacking.
The primary objective of this randomized controlled trial is to determine whether different pulse oximeter probe replacement intervals influence the incidence of pressure injuries in adult ICU patients. The findings are expected to provide evidence for establishing standardized clinical protocols for pulse oximeter probe repositioning and contribute to the prevention of medical device-related pressure injuries in critically ill adults.
Study Type
Enrollment (Estimated)
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
-
Ankara, Turkey (Türkiye)
- Univerisy of HelathSciences Turkiye Gulhane Faculty of Nursing
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- Adults aged 18 years or older
- Written informed consent provided by the patient's legally authorized representative
- Patients monitored with a pulse oximeter in the intensive care unit (ICU)
- Glasgow Coma Scale (GCS) score of 8 or less
- Expected or actual ICU stay of more than 72 hours
Exclusion Criteria:
- Patients with severe peripheral edema
- Patients with dermatological conditions that impair skin integrity
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Intervention Group
Patients will have a pulse oximeter probe placed on the right index finger.
The probe site will remain unchanged for 2 hours.
At the end of the 2-hour period, the probe will be removed, and the skin will be assessed for pressure injury using the Skin Assessment Form.
|
The pulse oximeter probe will be placed on the patient's right index finger and repositioned every 2 hours.
After 2 hours, the probe will be removed, the skin will be assessed for pressure injury using the Skin Assessment Form, and the probe will be repositioned according to the study protocol.
|
|
Active Comparator: Control Group
Patients will receive routine intensive care.
The pulse oximeter probe will remain in the same position for 4 hours, consistent with standard ICU practice.
At the end of the 4-hour period, the probe will be removed, and the skin will be assessed for pressure injury using the Skin Assessment Form.
|
The pulse oximeter probe will remain in the same position for 4 hours in accordance with routine intensive care unit practice.
After 4 hours, the probe will be removed, the skin will be assessed for pressure injury using the Skin Assessment Form, and routine care will continue.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Incidence of Medical Device-Related Pressure Injury at the Pulse Oximeter Probe Site
Time Frame: Up to 4 hours after pulse oximeter probe placement
|
The primary outcome is the incidence of medical device-related pressure injury (MDRPI) associated with pulse oximeter probe application in adult intensive care unit patients. Skin assessments will be performed using the Skin Assessment Form developed by the investigators based on the literature and the European Pressure Ulcer Advisory Panel (EPUAP) guidelines. The assessment includes: Presence or absence of medical device-related pressure injury Non-blanchable erythema Skin moisture Skin integrity Presence and severity of edema Tissue firmness Palpation findings Local skin temperature changes Pressure injury stage (Stage 1, Stage 2, Stage 3, Stage 4, Deep Tissue Injury, or Unstageable) The incidence of pressure injury will be compared between patients whose pulse oximeter probe is repositioned every 2 hours and those whose probe is repositioned every 4 hours. |
Up to 4 hours after pulse oximeter probe placement
|
Collaborators and Investigators
Sponsor
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Estimated)
Study Completion (Estimated)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 1616161616
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Pressure Ulcer (PU)
-
McMaster UniversityQueen's University; Kindera Living; Room 217 FoundationNot yet recruitingPressure Injury | Pressure Injuries | Pressure Ulcer (PU)Canada
-
Ankara Medipol UniversityDr. Lutfi Kirdar Kartal Training and Research Hospital; Fenerbahce UniversityNot yet recruitingPressure Ulcer (PU)
-
Sequence LifeScience, Inc.Serena GroupRecruitingSkin Ulcer | Pressure Ulcer of Skin | Chronic Ulcer | Pressure Sore | Pressure Ulcer (PU) | Pressure WoundUnited States
-
Acibadem Atasehir HospitalCompletedSurgical Wound | Tracheostomy Complication | Pressure Ulcer (PU)Turkey (Türkiye)
-
Selcuk UniversityGazi UniversityCompletedWheelchair Users | Pressure Ulcer Prevention | Pressure Ulcer (PU)Turkey (Türkiye)
-
Umeå UniversityKarolinska Institutet; Luleå University of Technology; Skellefteå MunicipalityActive, not recruitingHard-to-heal Wounds | Venous Leg Ulcer (VLU) | Arterial Leg Ulcer | Pressure Ulcer (PU)Sweden
-
Cellution BiologicsNot yet recruitingDiabetic Foot Ulcer (DFU) | Venous Leg Ulcer (VLU) | Pressure Ulcer (PU)
-
Benjamín Gonzalo Rodríguez MéndezCentro Medico IssemymRecruitingVenous Leg Ulcer | Chronic Wound | Wound Dehiscence | Arterial Ulcer | Diabetic Foot Ulcer (DFU) | Pressure Ulcer (PU)Mexico
-
Hiroshima UniversityNot yet recruitingVentilator Acquired Pneumonia | Central Line Associated Blood Stream Infections (CLABSI) | Pressure Ulcer (PU) | Medical Device Related Pressure Ulcer (MDRPU)Bangladesh, Japan
-
BioLab HoldingsCompletedDiabetic Foot Ulcer (DFU) | Venous Leg Ulcer (VLU) | Pressure Ulcer (PU)United States
Clinical Trials on Pulse Oximeter Probe Repositioning Every 2 Hours
-
Imperial College LondonCompletedCovid19 | Pulmonary DiseaseUnited Kingdom
-
Hacettepe UniversityNot yet recruiting
-
University of Alabama at BirminghamRecruitingBreastfeeding | Breastmilk ExpressionUnited States
-
Inova Health Care ServicesTerminatedPregnancy | Neonatal Hypoglycemia | Gestational Diabetes Mellitus, Class A2United States
-
Sheba Medical CenterUnknown
-
ReAlta Life Sciences, Inc.FGK Clinical Research GmbHCompleted
-
Hospital General de MexicoNot yet recruitingAdverse Effect | Hemoglobin | Iron Deficiencies | Iron-deficiency Anemia (IDA)Mexico
-
Innoviva Specialty TherapeuticsEntasis TherapeuticsRecruitingAcinetobacter Baumannii-calcoaceticus Complex Infection (ABC)United States
-
Spirig Pharma Ltd.CompletedSkin Alterations Associated With Atopic DermatitisGermany
-
Emalex Biosciences Inc.ICON Early Phase Services; NuventraCompleted